Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

The result is what’s known as a “recombinant protein vaccine.” It’s made without live or dead versions of H5N1, relying on bits of genetic material from the virus to trigger the mouse’s ...

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

The newest, updated Covid-19 vaccines are now FDA-approved and available, including the mRNA ones from Pfizer-BioNTech and Moderna and the recombinant one from Novavax.

Recombinant therapeutics market surges to $960.4B by 2035, fueled by biotech advances, targeted therapies, and rising global ...

Loopworm, a Bengaluru-based biomanufacturing company developing insect-derived proteins, has raised $3.25 million Pre-Series ...